Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Shalini Shenoy, MD
Healthcare Provider Professor of Pediatrics
Washington University School of Medicine
Medical Building Three
1020 N. Mason Road
Suite 110
St. Louis, Missouri, United States
Dr. Shenoy is currently working as professor of pediatrics in the division of Hematology/Oncology and General Pediatrics at Washington University School of Medicine. She also serves as Director, Pediatric Stem Cell Transplant Program at St. Louis Children’s Hospital.
She is the prinicipal investigator of national trials of unrelated donor transplantation for severe sickle cell disease termed as the SCURT Trial (Bone Marrow Transplant Clinical Trials Network 0601, NHLBI) and thalassemia termed as the URTH Trial (Thalassemia Clinical Research Network, NHLBI).
Dr. Shenoy’s research interests are focused on stem cell transplants for non-malignant disorders, reduced intensity transplants, and the immunologic mechanisms of graft rejection, graft versus host disease (GVHD), and immune reconstitution following stem cell transplantation (SCT).
Representative Publications:
A trial of unrelated donor marrow transplantation for children with severe sickle cell disease
Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions
Has stem cell transplantation come of age in the treatment of sickle cell disease?
Related Content
-
Webinar Series: Sickle Cell Science: Path to Progress – Bone Marrow Transplants, Other Therapies, and Sickle C...To commemorate Sickle Cell Awareness Mon...
-
SCDAA Teams with MedicAlert Foundation to Improve Emergency Outcomes During Sickle Cell Crises[Hanover, Md., June 26, 2023] – The Si...
-
Diggs-Kraus Sickle Cell CenterThe Diggs-Kraus Sickle Cell Center at Re...
-
Today’s Faces of Sickle Cell Disease: Tosin OlaDuring a long hospitalization in 2005, T...
-
Marjorie Dejoie-Brewer, MDMarjorie DeJoie-Brewer, MD, is a medical...
-
A Developmental Examination of Pain Among Youth with Sickle Cell DiseaseIntroduction: Sickle cell disease (SCD)...
-
Pediatric Residents’ Perceived Barriers to Opioid Use in Sickle Cell Disease Pain ManagementObjective: Current guidelines recommend...
+myBinder